Published in Arthritis Rheum on February 01, 1997
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood (2007) 1.72
Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf (2009) 1.33
Sjögren's syndrome: an old tale with a new twist. Arch Immunol Ther Exp (Warsz) (2009) 1.16
Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis (2001) 1.06
Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis (2008) 0.95
Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res Ther (2011) 0.90
The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases. Front Immunol (2013) 0.90
Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res (2002) 0.87
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation. Int J Rheumatol (2010) 0.87
Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome. Clin Exp Immunol (2007) 0.85
The important role of T cells and receptor expression in Sjögren's syndrome. Scand J Immunol (2013) 0.84
Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome. Curr Immunol Rev (2013) 0.78
Rituximab treatment for Sjogren syndrome-associated non-Hodgkin's lymphoma: case series. Rheumatol Int (2011) 0.75
Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83
Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1980) 4.04
Myocyte death in the failing human heart is gender dependent. Circ Res (1999) 3.38
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80
Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A (1998) 2.60
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science (1993) 2.28
A case-control study of gastric cancer and diet in Italy. Int J Cancer (1989) 2.17
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med (1992) 2.13
Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med (1998) 2.13
Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13
Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemost (1994) 2.03
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J (2010) 1.83
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol (1993) 1.77
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) (2006) 1.74
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol (2006) 1.71
Evidence for a multifactorial control of serum erythropoietin concentration in liver disease. Clin Chim Acta (1993) 1.69
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol (1998) 1.64
Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. AIDS (2001) 1.64
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. J Natl Cancer Inst (2001) 1.63
Hypokalaemic alkalosis, acquired Gitelman's and Bartter's syndrome in chronic sialoadenitis. Br J Rheumatol (1997) 1.63
Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood (1994) 1.58
The xanthogranulomatous process. Xanthogranulomatous inflammation. Pathol Res Pract (1988) 1.55
Colour Doppler ultrasonography evaluation of vascularization in the wrist and finger joints in rheumatoid arthritis patients and healthy subjects. Eur J Radiol (2010) 1.53
Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol (2000) 1.52
Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis. Clin Infect Dis (2001) 1.52
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood (2001) 1.52
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum (1996) 1.51
Monocytoid B-cell lymphoma with bone marrow and peripheral blood involvement at presentation. Am J Clin Pathol (1989) 1.51
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit. Crit Care Med (1999) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res (1994) 1.49
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol (1999) 1.47
Analysis of human herpesvirus type 8 infection in AIDS-related and AIDS-unrelated primary central nervous system lymphoma. J Infect Dis (1997) 1.47
Metastasizing dermal squamomelanocytic tumour: more evidences. J Eur Acad Dermatol Venereol (2011) 1.46
Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. Hum Pathol (1995) 1.45
Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein. J Virol (1987) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Occupation and soft-tissue sarcoma in northeastern Italy. Cancer Causes Control (1992) 1.41
Analysis of disability in knee osteoarthritis. Relationship with age and psychological variables but not with radiographic score. J Rheumatol (1991) 1.40
Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment. J Hepatol (1994) 1.40
Expression of natural killer antigens in a subset of 'non-T, non-B lymphoma/leukaemia with histiocytic features'. Br J Haematol (1990) 1.39
Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome. Lancet (2000) 1.39
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS (1989) 1.38
Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol (1998) 1.37
Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford) (2002) 1.37
Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats. Diabetologia (1997) 1.37
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer (1998) 1.36
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophilia. Clin Microbiol Infect (2006) 1.35
Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc Natl Acad Sci U S A (1988) 1.34
TTF-1 gene expression in human lung tumours. Eur J Cancer (1996) 1.33
A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer (1990) 1.32
Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer (1999) 1.31
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
Review of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of head and neck. Ann Otol Rhinol Laryngol (1999) 1.30
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene (1992) 1.30
Phosphorylation of threonine in the proline-rich carboxy-terminal region of simian virus 40 large T antigen. J Virol (1981) 1.29
Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res (1993) 1.29
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol (1997) 1.29
Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey. Digestion (2000) 1.28
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
Purified polyoma virus medium T antigen has tyrosine-specific protein kinase activity but no significant phosphatidylinositol kinase activity. Mol Cell Biol (1986) 1.27
Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev (2000) 1.26
Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res (1997) 1.25
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health (1982) 1.24
Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis (1994) 1.24
The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype. J Immunol (1985) 1.24
Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia (1998) 1.23
Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol (1995) 1.22
Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol (2000) 1.21
Dietary factors and non-Hodgkin's lymphoma: a case-control study in the northeastern part of Italy. Nutr Cancer (1989) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer (1997) 1.20
Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Anticancer Res (2002) 1.20
The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int J Cancer (1994) 1.20
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer (2006) 1.20